In recent years, Ozempic® (Semaglutide) has attracted attention not only for managing type 2 diabetes but also for its noticeable effects on weight control. This isn’t merely a side effect—it’s a clinically observed benefit that’s changing the way we think about long-term metabolic support.
When we talk about cancer care, the focus often centers on active treatments like surgery, chemotherapy, or targeted therapies. However, supportive care strategies also play a critical role in helping the body recover, maintain stability, and rebuild its strength. Among these strategies, intravenous nutritional immunoglobulin therapy (IVIG) is emerging as a promising and gentle option for additional support.
In cancer care, most of the focus is placed on tumor markers, imaging results, or responses to treatment. Yet one often-overlooked blood marker—albumin—can quietly reflect a patient’s overall condition, prognosis, and even survival.
Though seemingly simple, this protein tells a deeper story about the body’s nutritional status, inflammation levels, and recovery capacity.
Have you been experiencing brain fog, memory lapses, or trouble focusing—without any clear reason?
While stress, poor sleep, and aging are often blamed, there might be an invisible culprit affecting your brain health: heavy metal accumulation in the body.
How BMS Supports Recovery Through Our Neurocognitive Health Program
When people hear the word cancer, they often think of tumors, genetic mutations, and clinical treatments like surgery, radiation, or chemotherapy. But in reality, cancer affects far more than just the physical body — it also places immense strain on the brain and emotional systems.
When we talk about early cancer detection, most people think of imaging tests or tumor markers.
These tools are valuable for identifying structural abnormalities or elevated markers — in other words, when a disease has already begun to manifest.
But what if you could go one step earlier?
Before anything is visible or measurable, is there a way to understand your underlying genetic risk?
Have you ever had a health checkup that came back “normal,” yet you still felt fatigued, foggy, or out of balance?
Or known someone who was diagnosed with cancer shortly after receiving clear test results?
These situations highlight a crucial gap:
Traditional checkups are important—but they focus on detecting existing issues, not predicting future risks.
You may regularly undergo health checkups, including cancer markers and imaging scans.
Yet, it’s not uncommon to hear of individuals being diagnosed with cancer shortly after receiving “normal” test results. Why does this happen?
The truth is, traditional screenings, while essential, have their limitations.
Some risks remain hidden—undetectable by standard scans or blood markers—because they originate at a cellular or molecular level, far before tumors form.
This is where RGCC (Research Genetic Cancer Centre) testing plays a unique and valuable role.
Have you ever felt this way?
You’ve tried all kinds of supplements and skincare products…
But your skin remains dull, your mood is low, and your energy just doesn’t come back.
Despite your best efforts, brain fog, fatigue, and trouble concentrating persist.
Before you blame the products, consider this:
What if your body is overloaded with invisible toxins — like lead and arsenic?
When summer arrives, most people focus on avoiding heatstroke, staying hydrated, and protecting their skin from the sun. But there’s another hidden impact of extreme heat that’s often overlooked:it can quietly disrupt your nervous system.